153 related articles for article (PubMed ID: 12558341)
1. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature.
Roy K; Hay G; Andragetti R; Taylor A; Goldberg D; Wiessing L
Epidemiol Infect; 2002 Dec; 129(3):577-85. PubMed ID: 12558341
[TBL] [Abstract][Full Text] [Related]
2. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010.
Wiessing L; Likatavicius G; Hedrich D; Guarita B; van de Laar MJ; Vicente J
Euro Surveill; 2011 Dec; 16(48):. PubMed ID: 22172300
[TBL] [Abstract][Full Text] [Related]
3. Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.
Corson S; Greenhalgh D; Palmateer N; Weir A; Hutchinson S
Int J Drug Policy; 2011 Mar; 22(2):102-8. PubMed ID: 21112759
[TBL] [Abstract][Full Text] [Related]
4. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.
Aitken CK; Lewis J; Tracy SL; Spelman T; Bowden DS; Bharadwaj M; Drummer H; Hellard M
Hepatology; 2008 Dec; 48(6):1746-52. PubMed ID: 18844233
[TBL] [Abstract][Full Text] [Related]
5. Current Burden of Hepatitis C Virus Infection Among Injecting Drug Users: A Mini Systematic Review of Prevalence Studies.
Rafiq SM; Banik GR; Khan S; Rashid H; Khandaker G
Infect Disord Drug Targets; 2014; 14(2):93-100. PubMed ID: 25313101
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
Roy KM; Hutchinson SJ; Wadd S; Taylor A; Cameron SO; Burns S; Molyneaux P; McIntyre PG; Goldberg DJ
Epidemiol Infect; 2007 Apr; 135(3):433-42. PubMed ID: 16893486
[TBL] [Abstract][Full Text] [Related]
7. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of hepatitis C virus infection among injecting drug users in Australia.
Crofts N; Jolley D; Kaldor J; van Beek I; Wodak A
J Epidemiol Community Health; 1997 Dec; 51(6):692-7. PubMed ID: 9519134
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Xia X; Luo J; Bai J; Yu R
Public Health; 2008 Oct; 122(10):990-1003. PubMed ID: 18486955
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.
Satoh Y; Hino K; Kato T; Mizokami M; Yamashita S; Nakamura H; Okita K
J Gastroenterol Hepatol; 2004 Nov; 19(11):1305-11. PubMed ID: 15482539
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
13. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
Platt L; Sutton AJ; Vickerman P; Koshkina E; Maximova S; Latishevskaya N; Hickman M; Bonell C; Parry J; Rhodes T
Eur J Public Health; 2009 Aug; 19(4):428-33. PubMed ID: 19349288
[TBL] [Abstract][Full Text] [Related]
14. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users.
Roy E; Alary M; Morissette C; Leclerc P; Boudreau JF; Parent R; Rochefort J; Claessens C;
Int J STD AIDS; 2007 Jan; 18(1):23-7. PubMed ID: 17326858
[TBL] [Abstract][Full Text] [Related]
15. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
16. Surveillance and epidemiology of hepatitis B and C in Europe - a review.
Rantala M; van de Laar MJ
Euro Surveill; 2008 May; 13(21):. PubMed ID: 18761967
[TBL] [Abstract][Full Text] [Related]
17. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
Fuller CM; Ompad DC; Galea S; Wu Y; Koblin B; Vlahov D
J Urban Health; 2004 Mar; 81(1):20-4. PubMed ID: 15047780
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.
Balogun MA; Murphy N; Nunn S; Grant A; Andrews NJ; Teo CG; Ramsay ME; Parry JV
Epidemiol Infect; 2009 Jul; 137(7):980-7. PubMed ID: 19102796
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection and related risk factors among injection drug users in Montenegro.
Baćak V; Laušević D; Mugoša B; Vratnica Z; Terzić N
Eur Addict Res; 2013; 19(2):68-73. PubMed ID: 23006531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
